| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Hypertension. 2007;49:604.)
© 2007 American Heart Association, Inc.
Original Articles, Part 2 |
From the Medical Faculty of the Charité (F.H., R.D., J.J., F.Q., L.H., D.N.M., F.C.L.), Franz-Volhard Clinic, HELIOS Klinikum, Berlin, Germany; the Max-Delbrück Center for Molecular Medicine (G.W., D.N.M., F.C.L.), Berlin, Germany; the Department of Obstetrics and Gynecology, Ulleval University Hospital (N.K.H., A.C.S.), and the Faculty of Medicine (N.K.H., A.C.S.), University of Oslo, Oslo, Norway.
Correspondence to Ralf Dechend, Franz Volhard Clinic, Wiltbergstrasse 50, 13125 Berlin, Germany. E-mail ralf.dechend{at}charite.de
The renin-angiotensin system (RAS) participates in preeclampsia; however, the relative contributions from the circulating RAS and the tissue-based, uteroplacental RAS are unknown. We hypothesized that the tissue-based uteroplacental RAS is dysregulated in preeclampsia. We performed microarray and gene expression studies and confirmed the findings on the protein level by immunohistochemistry in ureteroplacental units from 10 preeclamptic women and 10 women with uneventful pregnancies. All of the women were delivered by cesarean section. We also analyzed plasma renin activity and circulating agonistic angiotensin II type 1 (AT1) receptor autoantibodies. In preeclampsia, we found that the angiotensin II AT1 receptor gene was 5-fold upregulated in decidua (maternal origin). We also found AT1 autoantibodies in preeclamptic women and in their offspring by neonatal cardiomyocyte bioassay compared with women with normal pregnancies and their infants (mother: 17.5±2.2 versus 0.05±0.4; fetus: 14.5±1.8 versus 0.5±0.5
bpm). Gene expressions for renin (35.0-fold), angiotensin-converting enzyme (2.9-fold), and angiotensinogen (8.9-fold) were higher in decidua than placenta (fetal origin) in both control and preeclamptic women, whereas the AT1 receptor was expressed 10-fold higher in placenta than in decidua in both groups. Our findings elucidate the ureteroplacental unit RAS in preeclamptic and normal pregnancies. We found that, in preeclampsia, the AT1 receptor expression is particularly high in decidua, combined with pregnancy-specific tissue RAS involving decidual angiotensin II production and AT1 autoantibodies. We also showed that AT1 autoantibodies cross the ureteroplacental barrier. These components could participate in the pathophysiology of preeclampsia.
Key Words: preeclampsia renin angiotensin AT1 receptor gene expression proteomics
This article has been cited by other articles:
![]() |
C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera Peptide Hormone Regulation of Angiogenesis Physiol Rev, October 1, 2009; 89(4): 1177 - 1215. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Anton, D. C. Merrill, L. A. A. Neves, D. I. Diz, J. Corthorn, G. Valdes, K. Stovall, P. E. Gallagher, C. Moorefield, C. Gruver, et al. The Uterine Placental Bed Renin-Angiotensin System in Normal and Preeclamptic Pregnancy Endocrinology, September 1, 2009; 150(9): 4316 - 4325. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. P. Thomas, J. I. Andrews, N. S. Raikwar, E. A. Kelley, F. Herse, R. Dechend, T. G. Golos, and K. Z. Liu A Recently Evolved Novel Trophoblast-Enriched Secreted Form of fms-Like Tyrosine Kinase-1 Variant Is Up-Regulated in Hypoxia and Preeclampsia J. Clin. Endocrinol. Metab., July 1, 2009; 94(7): 2524 - 2530. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sugulle, R. Dechend, F. Herse, M. S. Weedon-Fekjaer, G. M. Johnsen, K. B. Brosnihan, L. Anton, F. C. Luft, K. C. Wollert, T. Kempf, et al. Circulating and Placental Growth-Differentiation Factor 15 in Preeclampsia and in Pregnancy Complicated by Diabetes Mellitus Hypertension, July 1, 2009; 54(1): 106 - 112. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Herse, Bai Youpeng, A. C. Staff, J. Yong-Meid, R. Dechend, and Zhou Rong Circulating and Uteroplacental Adipocytokine Concentrations in Preeclampsia Reproductive Sciences, June 1, 2009; 16(6): 584 - 590. [Abstract] [PDF] |
||||
![]() |
W. W. Bakker, R. H. Henning, W. J. van Son, M. G. van Pampus, J. G. Aarnoudse, K. E. Niezen-Koning, T. Borghuis, R. M. Jongman, H. van Goor, K. Poelstra, et al. Vascular Contraction and Preeclampsia: Downregulation of the Angiotensin Receptor 1 by Hemopexin In Vitro Hypertension, June 1, 2009; 53(6): 959 - 964. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Everts, P. Chavatte-Palmer, A. Razzak, I. Hue, C. A. Green, R. Oliveira, X. Vignon, S. L. Rodriguez-Zas, X. C. Tian, X. Yang, et al. Aberrant gene expression patterns in placentomes are associated with phenotypically normal and abnormal cattle cloned by somatic cell nuclear transfer Physiol Genomics, October 8, 2008; 33(1): 65 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Anton and K. B. Brosnihan Review: Systemic and uteroplacental renin--angiotensin system in normal and pre-eclamptic pregnancies Therapeutic Advances in Cardiovascular Disease, October 1, 2008; 2(5): 349 - 362. [Abstract] [PDF] |
||||
![]() |
S. A. Karumanchi and M. D. Lindheimer Preeclampsia Pathogenesis: "Triple A Rating"-Autoantibodies and AntiAngiogenic Factors Hypertension, April 1, 2008; 51(4): 991 - 992. [Full Text] [PDF] |
||||
![]() |
B. D. LaMarca, J. Gilbert, and J. P. Granger Recent Progress Toward the Understanding of the Pathophysiology of Hypertension During Preeclampsia Hypertension, April 1, 2008; 51(4): 982 - 988. [Full Text] [PDF] |
||||
![]() |
C. C. Zhou, S. Ahmad, T. Mi, S. Abbasi, L. Xia, M.-C. Day, S. M. Ramin, A. Ahmed, R. E. Kellems, and Y. Xia Autoantibody From Women With Preeclampsia Induces Soluble Fms-Like Tyrosine Kinase-1 Production via Angiotensin Type 1 Receptor and Calcineurin/Nuclear Factor of Activated T-Cells Signaling Hypertension, April 1, 2008; 51(4): 1010 - 1019. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Anton, D. C. Merrill, L. A.A. Neves, K. Stovall, P. E. Gallagher, D. I. Diz, C. Moorefield, C. Gruver, C. M. Ferrario, and K. B. Brosnihan Activation of Local Chorionic Villi Angiotensin II Levels But Not Angiotensin (1-7) in Preeclampsia Hypertension, April 1, 2008; 51(4): 1066 - 1072. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Hering, F. Herse, S. Verlohren, J.-K. Park, M. Wellner, F. Qadri, R. Pijnenborg, A. C. Staff, B. Huppertz, D. N. Muller, et al. Trophoblasts Reduce the Vascular Smooth Muscle Cell Proatherogenic Response Hypertension, February 1, 2008; 51(2): 554 - 559. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Verlohren, M. Niehoff, L. Hering, N. Geusens, F. Herse, A. N. Tintu, A. Plagemann, F. LeNoble, R. Pijnenborg, D. N. Muller, et al. Uterine Vascular Function in a Transgenic Preeclampsia Rat Model Hypertension, February 1, 2008; 51(2): 547 - 553. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xia, C. C. Zhou, S. M. Ramin, and R. E. Kellems Angiotensin Receptors, Autoimmunity, and Preeclampsia J. Immunol., September 15, 2007; 179(6): 3391 - 3395. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Stepan and T. Walther Questionable Role of the Angiotensin II Receptor Subtype 1 Autoantibody in the Pathogenesis of Preeclampsia Hypertension, July 1, 2007; 50(1): e3 - e3. [Full Text] [PDF] |
||||
![]() |
R. Dechend Response to Questionable Role of the Angiotensin II Receptor Subtype 1 Autoantibody in the Pathogenesis of Preeclampsia: There Is No Single Universal Preeclampsia Cause Hypertension, July 1, 2007; 50(1): e4 - e4. [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2007 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |